TrialLeukemia research2010

Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.

Judith E Karp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.